{"gene":"ETFA","run_date":"2026-06-09T23:54:43","timeline":{"discoveries":[{"year":2021,"finding":"EZH2, a transcriptional factor, activates ETFA expression by enhancing methylation of its promoter in colorectal cancer cells; lncRNA NBPF4 downregulates EZH2 and thereby suppresses ETFA expression.","method":"RNA pull-down assay, RNA immunoprecipitation, luciferase activity assay, Western blotting, qRT-PCR, silencing/overexpression in HCT116 and SW260 cells","journal":"Journal of cellular and molecular medicine","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — multiple orthogonal methods (RIP, luciferase, Western blot) in single lab; promoter methylation-mediated activation of ETFA by EZH2 supported but not independently replicated","pmids":["34405537"],"is_preprint":false},{"year":2024,"finding":"PMP-derived miR-320b directly targets ETFA mRNA in HUVECs; knockdown of ETFA (via miR-320b mimics) promoted HUVEC viability, proliferation, and migration under hypoxic conditions, and reduced oxidative stress and inflammatory markers (MDA, ROS, IL-6, TNF-α, IL-1β).","method":"miRNA target validation (implied luciferase/expression assays), Western blotting, MTT, EdU, wound healing assays in CoCl2-treated HUVECs","journal":"International heart journal","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, target relationship inferred from expression changes; abstract does not explicitly confirm direct 3'UTR luciferase validation of ETFA as miR-320b target","pmids":["38556340"],"is_preprint":false},{"year":2025,"finding":"A pomalidomide-gefitinib PROTAC compound (P-G) directly binds and thermally stabilizes ETFA protein, enhancing ETFA-mediated ATP/energy production in EGFR-TKI-resistant NSCLC cells, which promotes apoptosis sensitization.","method":"Thermal shift assay (CETSA-type stabilization), cellular energy production assays, Western blotting, xenograft tumor model","journal":"Bioorganic chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct binding of small molecule to ETFA shown by thermal stabilization with functional consequence (ATP generation), single lab, single study","pmids":["40815992"],"is_preprint":false},{"year":2026,"finding":"The transcription factor Irx3 directly binds the Etfa promoter and upregulates Etfa expression in cardiomyocytes; the Irx3-Etfa axis suppresses ferroptosis and attenuates pathological cardiac hypertrophy. Etfa knockdown abolished the cardioprotective effects of Irx3 overexpression, placing Etfa downstream of Irx3 in this pathway.","method":"AAV-mediated overexpression and shRNA knockdown in vivo (TAC mouse model) and in vitro (angiotensin II cardiomyocyte model), transcription factor binding assay (promoter binding), transcriptomic analysis, ferroptosis markers","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis (Etfa KD rescues Irx3 OE phenotype), direct promoter binding shown, orthogonal in vivo and in vitro models; single lab","pmids":["41631390"],"is_preprint":false},{"year":2022,"finding":"A homozygous promoter variant in ETFA (c.-85G>A) causes decreased ETFA protein expression and reduced promoter activity, establishing that the ETFA promoter region is required for normal ETFA expression and that its disruption leads to MADD.","method":"Whole genome sequencing, promoter luciferase reporter assay, Western blotting of lymphoblast protein","journal":"American journal of medical genetics. Part A","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — luciferase assay directly tested promoter activity, Western blot confirmed reduced protein; single lab but two orthogonal methods","pmids":["36579410"],"is_preprint":false}],"current_model":"ETFA (electron transfer flavoprotein subunit alpha) is a mitochondrial protein whose expression is driven by its promoter (regulated by transcription factor Irx3 and subject to EZH2-mediated epigenetic activation), and whose protein directly participates in mitochondrial energy (ATP) production; the Irx3-ETFA axis suppresses ferroptosis and cardiac hypertrophy, and loss-of-function ETFA variants (coding or promoter) cause multiple acyl-CoA dehydrogenase deficiency (MADD/glutaric aciduria type II) by impairing fatty acid and amino acid oxidation."},"narrative":{"mechanistic_narrative":"ETFA encodes a mitochondrial protein that directly participates in cellular energy (ATP) production, a role demonstrated when a small-molecule PROTAC that binds and thermally stabilizes ETFA enhanced ETFA-mediated ATP generation in NSCLC cells [PMID:40815992]. Beyond its bioenergetic function, ETFA serves as a downstream effector in stress and disease pathways: in cardiomyocytes the transcription factor Irx3 directly binds the Etfa promoter and upregulates its expression, and this Irx3–Etfa axis suppresses ferroptosis and attenuates pathological cardiac hypertrophy, with Etfa knockdown abolishing the cardioprotective effect of Irx3 [PMID:41631390]. ETFA expression is regulated at the promoter level by multiple inputs, including EZH2-mediated promoter methylation in colorectal cancer cells [PMID:34405537] and post-transcriptional targeting of ETFA mRNA by miR-320b in endothelial cells [PMID:38556340]. A homozygous ETFA promoter variant (c.-85G>A) reduces promoter activity and ETFA protein, establishing that intact ETFA expression is required to prevent multiple acyl-CoA dehydrogenase deficiency (MADD) [PMID:36579410]. Detailed enzymatic and structural characterization of ETFA's role in mitochondrial electron transfer has not been described in the available corpus.","teleology":[{"year":2021,"claim":"Established that ETFA expression is epigenetically controlled, identifying EZH2-mediated promoter methylation as an activating input subject to lncRNA regulation.","evidence":"RNA pull-down, RIP, luciferase, and silencing/overexpression in colorectal cancer cell lines","pmids":["34405537"],"confidence":"Medium","gaps":["Does not test the bioenergetic or metabolic consequences of altered ETFA levels","Promoter methylation-mediated activation not independently replicated"]},{"year":2022,"claim":"Demonstrated that the ETFA promoter region is functionally required for normal expression, linking promoter disruption directly to MADD pathology.","evidence":"Whole genome sequencing of a patient, promoter luciferase reporter assay, and Western blot of lymphoblasts","pmids":["36579410"],"confidence":"Medium","gaps":["Single family/variant","Does not resolve the downstream enzymatic defect at the protein level"]},{"year":2024,"claim":"Identified post-transcriptional control of ETFA by miR-320b in endothelial cells, connecting ETFA levels to oxidative stress and inflammatory output under hypoxia.","evidence":"miRNA mimic/knockdown, Western blot, and proliferation/migration assays in CoCl2-treated HUVECs","pmids":["38556340"],"confidence":"Low","gaps":["Direct 3'UTR luciferase validation of ETFA as a miR-320b target not explicitly confirmed","Target relationship inferred from expression changes","Single lab"]},{"year":2025,"claim":"Provided direct evidence that ETFA protein drives ATP/energy production, showing a small molecule that stabilizes ETFA enhances its bioenergetic function.","evidence":"Thermal shift (CETSA-type) binding assay, cellular energy production assays, and xenograft model in EGFR-TKI-resistant NSCLC","pmids":["40815992"],"confidence":"Medium","gaps":["Mechanism of how ETFA stabilization increases ATP not resolved at the enzymatic level","Single study"]},{"year":2026,"claim":"Placed ETFA as a direct transcriptional target and effector of Irx3 that suppresses ferroptosis and cardiac hypertrophy, defining a protective signaling axis.","evidence":"AAV overexpression/knockdown in TAC mouse and angiotensin II cardiomyocyte models, promoter binding assay, and transcriptomics with ferroptosis markers","pmids":["41631390"],"confidence":"Medium","gaps":["Molecular link between ETFA bioenergetic function and ferroptosis suppression unresolved","Single lab"]},{"year":null,"claim":"The biochemical mechanism by which ETFA mediates mitochondrial electron transfer and how its energy function connects to ferroptosis and MADD pathology remains uncharacterized in this corpus.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural model or enzymatic characterization in the timeline","No identified direct protein partners in the electron transfer chain"]}],"mechanism_profile":{"molecular_activity":[],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[2]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[2]}],"complexes":[],"partners":[],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P13804","full_name":"Electron transfer flavoprotein subunit alpha, mitochondrial","aliases":[],"length_aa":333,"mass_kda":35.1,"function":"Heterodimeric electron transfer flavoprotein that accepts electrons from several mitochondrial dehydrogenases, including acyl-CoA dehydrogenases, glutaryl-CoA and sarcosine dehydrogenase (PubMed:10356313, PubMed:15159392, PubMed:15975918, PubMed:27499296, PubMed:9334218). It transfers the electrons to the main mitochondrial respiratory chain via ETF-ubiquinone oxidoreductase (ETF dehydrogenase) (PubMed:9334218). Required for normal mitochondrial fatty acid oxidation and normal amino acid metabolism (PubMed:12815589, PubMed:1430199, PubMed:1882842)","subcellular_location":"Mitochondrion matrix","url":"https://www.uniprot.org/uniprotkb/P13804/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ETFA","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CSNK2B","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/ETFA","total_profiled":1310},"omim":[{"mim_id":"621252","title":"CATARACT, ALOPECIA, ORAL MUCOSAL DISORDER, AND PSORIASIS-LIKE SYNDROME; CAOP","url":"https://www.omim.org/entry/621252"},{"mim_id":"619219","title":"CHROMOSOME 2 OPEN READING FRAME 69; C2ORF69","url":"https://www.omim.org/entry/619219"},{"mim_id":"608053","title":"ELECTRON TRANSFER FLAVOPROTEIN, ALPHA POLYPEPTIDE; ETFA","url":"https://www.omim.org/entry/608053"},{"mim_id":"603355","title":"MEMBRANE-BOUND TRANSCRIPTION FACTOR PROTEASE, SITE 1; MBTPS1","url":"https://www.omim.org/entry/603355"},{"mim_id":"231680","title":"MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD","url":"https://www.omim.org/entry/231680"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Mitochondria","reliability":"Enhanced"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"liver","ntpm":244.8},{"tissue":"tongue","ntpm":244.5}],"url":"https://www.proteinatlas.org/search/ETFA"},"hgnc":{"alias_symbol":["GA2","EMA","MADD"],"prev_symbol":[]},"alphafold":{"accession":"P13804","domains":[{"cath_id":"3.40.50.620","chopping":"19-186","consensus_level":"high","plddt":97.2777,"start":19,"end":186},{"cath_id":"3.40.50.1220","chopping":"216-331","consensus_level":"high","plddt":97.4066,"start":216,"end":331}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P13804","model_url":"https://alphafold.ebi.ac.uk/files/AF-P13804-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P13804-F1-predicted_aligned_error_v6.png","plddt_mean":94.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ETFA","jax_strain_url":"https://www.jax.org/strain/search?query=ETFA"},"sequence":{"accession":"P13804","fasta_url":"https://rest.uniprot.org/uniprotkb/P13804.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P13804/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P13804"}},"corpus_meta":[{"pmid":"99746","id":"PMC_99746","title":"AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.","date":"1978","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/99746","citation_count":255,"is_preprint":false},{"pmid":"527942","id":"PMC_527942","title":"Purification and characterization of an activator protein for the degradation of glycolipids GM2 and GA2 by hexosaminidase A.","date":"1979","source":"Hoppe-Seyler's Zeitschrift fur physiologische Chemie","url":"https://pubmed.ncbi.nlm.nih.gov/527942","citation_count":173,"is_preprint":false},{"pmid":"3140234","id":"PMC_3140234","title":"Both GA2, GM2, and GD2 synthases and GM1b, GD1a, and GT1b synthases are single enzymes in Golgi vesicles from rat liver.","date":"1988","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/3140234","citation_count":167,"is_preprint":false},{"pmid":"2118658","id":"PMC_2118658","title":"Use of brefeldin A to define sites of glycosphingolipid synthesis: GA2/GM2/GD2 synthase is trans to the brefeldin A block.","date":"1990","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2118658","citation_count":97,"is_preprint":false},{"pmid":"33203832","id":"PMC_33203832","title":"FIS1 encodes a GA2-oxidase that regulates fruit firmness in tomato.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33203832","citation_count":77,"is_preprint":false},{"pmid":"27998028","id":"PMC_27998028","title":"Ectopic expression of specific GA2 oxidase mutants promotes yield and stress tolerance in rice.","date":"2017","source":"Plant biotechnology journal","url":"https://pubmed.ncbi.nlm.nih.gov/27998028","citation_count":76,"is_preprint":false},{"pmid":"10477274","id":"PMC_10477274","title":"GA2/GM2/GD2 synthase localizes to the trans-golgi network of CHO-K1 cells.","date":"1999","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/10477274","citation_count":50,"is_preprint":false},{"pmid":"13950","id":"PMC_13950","title":"Ganglioside GM2 N-acetyl-beta-D-galactosaminidase and asialo GM2 (GA2) N-acetyl-beta-D-galactosaminidase; studies in human skin fibroblasts.","date":"1977","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/13950","citation_count":48,"is_preprint":false},{"pmid":"7961890","id":"PMC_7961890","title":"Cloned beta 1,4 N-acetylgalactosaminyltransferase synthesizes GA2 as well as gangliosides GM2 and GD2. GM3 synthesis has priority over GA2 synthesis for utilization of lactosylceramide substrate in vivo.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7961890","citation_count":31,"is_preprint":false},{"pmid":"19968785","id":"PMC_19968785","title":"EtfA catalyses the formation of dipicolinic acid in Clostridium perfringens.","date":"2009","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/19968785","citation_count":28,"is_preprint":false},{"pmid":"30976084","id":"PMC_30976084","title":"MtGA2ox10 encoding C20-GA2-oxidase regulates rhizobial infection and nodule development in Medicago truncatula.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30976084","citation_count":26,"is_preprint":false},{"pmid":"9363441","id":"PMC_9363441","title":"Beta 1,4 N-acetylgalactosaminyltransferase (GM2/GD2/GA2 synthase) forms homodimers in the endoplasmic reticulum: a strategy to test for dimerization of Golgi membrane proteins.","date":"1997","source":"Glycobiology","url":"https://pubmed.ncbi.nlm.nih.gov/9363441","citation_count":20,"is_preprint":false},{"pmid":"26362868","id":"PMC_26362868","title":"The regulation of ER export and Golgi retention of ST3Gal5 (GM3/GM4 synthase) and B4GalNAcT1 (GM2/GD2/GA2 synthase) by arginine/lysine-based motif adjacent to the transmembrane domain.","date":"2015","source":"Glycobiology","url":"https://pubmed.ncbi.nlm.nih.gov/26362868","citation_count":17,"is_preprint":false},{"pmid":"18269347","id":"PMC_18269347","title":"Calsenilin and CALP interact with the cytoplasmic tail of UDP-Gal:GA2/GM2/GD2 beta-1,3-galactosyltransferase.","date":"2008","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/18269347","citation_count":17,"is_preprint":false},{"pmid":"31351992","id":"PMC_31351992","title":"Characterization and expression in Pichia pastoris of a raw starch degrading glucoamylase (GA2) derived from Aspergillus flavus NSH9.","date":"2019","source":"Protein expression and purification","url":"https://pubmed.ncbi.nlm.nih.gov/31351992","citation_count":16,"is_preprint":false},{"pmid":"27154330","id":"PMC_27154330","title":"Sixteen years of evolution of human respiratory syncytial virus subgroup A in Buenos Aires, Argentina: GA2 the prevalent genotype through the years.","date":"2016","source":"Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/27154330","citation_count":16,"is_preprint":false},{"pmid":"9972878","id":"PMC_9972878","title":"Recombinant GM2-activator protein stimulates in vivo degradation of GA2 in GM2 gangliosidosis AB variant fibroblasts but exhibits no detectable binding of GA2 in an in vitro assay.","date":"1999","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/9972878","citation_count":12,"is_preprint":false},{"pmid":"34405537","id":"PMC_34405537","title":"NBPF4 mitigates progression in colorectal cancer through the regulation of EZH2-associated ETFA.","date":"2021","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34405537","citation_count":10,"is_preprint":false},{"pmid":"31996215","id":"PMC_31996215","title":"A case report of a mild form of multiple acyl-CoA dehydrogenase deficiency due to compound heterozygous mutations in the ETFA gene.","date":"2020","source":"BMC medical genomics","url":"https://pubmed.ncbi.nlm.nih.gov/31996215","citation_count":9,"is_preprint":false},{"pmid":"32253516","id":"PMC_32253516","title":"Phalaenopsis orchid miniaturization by overexpression of OsGA2ox6, a rice GA2-oxidase gene.","date":"2020","source":"Botanical studies","url":"https://pubmed.ncbi.nlm.nih.gov/32253516","citation_count":8,"is_preprint":false},{"pmid":"39744431","id":"PMC_39744431","title":"Ganglioside GA2-mediated caspase-11 activation drives macrophage pyroptosis aggravating intimal hyperplasia after arterial injury.","date":"2025","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39744431","citation_count":7,"is_preprint":false},{"pmid":"38556340","id":"PMC_38556340","title":"Platelet Microparticle-Derived MiR-320b Inhibits Hypertension with Atherosclerosis Development by Targeting ETFA.","date":"2024","source":"International heart journal","url":"https://pubmed.ncbi.nlm.nih.gov/38556340","citation_count":7,"is_preprint":false},{"pmid":"37180390","id":"PMC_37180390","title":"Conservation and divergence of expression of GA2-oxidase homeologs in apple (Malus x domestica Borkh.).","date":"2023","source":"Frontiers in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/37180390","citation_count":6,"is_preprint":false},{"pmid":"27652075","id":"PMC_27652075","title":"Human immunodeficiency virus and hepatitis B genotype G/A2 recombinant co-infection: a case study.","date":"2016","source":"SpringerPlus","url":"https://pubmed.ncbi.nlm.nih.gov/27652075","citation_count":6,"is_preprint":false},{"pmid":"21952371","id":"PMC_21952371","title":"Parametric optimization of feruloyl esterase production from Aspergillus terreus strain GA2 isolated from tropical agro-ecosystems cultivating sweet sorghum.","date":"2011","source":"Journal of microbiology and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/21952371","citation_count":5,"is_preprint":false},{"pmid":"25472694","id":"PMC_25472694","title":"Association between ETFA genotype and activity of superoxide dismutase, catalase and glutathione peroxidase in cryopreserved sperm of Holstein-Friesian bulls.","date":"2014","source":"Reproduction in domestic animals = Zuchthygiene","url":"https://pubmed.ncbi.nlm.nih.gov/25472694","citation_count":4,"is_preprint":false},{"pmid":"9426962","id":"PMC_9426962","title":"Appearance of beta 1,4 N-acetylgalactosaminyltransferase (glycosphingolipids GA2/GM2/GD2 synthase) in embryonic chicken vitreous humor during development.","date":"1997","source":"Current eye research","url":"https://pubmed.ncbi.nlm.nih.gov/9426962","citation_count":4,"is_preprint":false},{"pmid":"40815992","id":"PMC_40815992","title":"A pomalidomide-based gefitinib PROTAC degrader effectively inhibits lung cancer progression in EGFR-TKIs-acquired resistant models by targeting EGFR degradation and ETFA-mediated ATP generation.","date":"2025","source":"Bioorganic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/40815992","citation_count":3,"is_preprint":false},{"pmid":"15498585","id":"PMC_15498585","title":"ETS-1 transcription factor activates the expression of mouse UDP-Gal:GA2/GM2/GD2/GT2 galactosyltransferase gene.","date":"2004","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/15498585","citation_count":3,"is_preprint":false},{"pmid":"29142163","id":"PMC_29142163","title":"Strain improvement studies on Microbacterium foliorum GA2 for production of α-amylase in solid state fermentation: Biochemical characteristics and wash performance analysis at low temperatures.","date":"2017","source":"The Journal of general and applied microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/29142163","citation_count":3,"is_preprint":false},{"pmid":"36579410","id":"PMC_36579410","title":"A novel deleterious ETFA promoter variant causative of multiple acyl-CoA dehydrogenase deficiency.","date":"2022","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/36579410","citation_count":2,"is_preprint":false},{"pmid":"28709807","id":"PMC_28709807","title":"Identification of a new B4GalNAcT1 (GM2/GD2/GA2 synthase) isoform, and regulation of enzyme stability and intracellular transport by arginine-based motif.","date":"2017","source":"Biochimica et biophysica acta. Biomembranes","url":"https://pubmed.ncbi.nlm.nih.gov/28709807","citation_count":2,"is_preprint":false},{"pmid":"26517979","id":"PMC_26517979","title":"Virological characteristics of hepatitis B genotype G/A2 recombination virus in Japan.","date":"2015","source":"Hepatology research : the official journal of the Japan Society of Hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/26517979","citation_count":2,"is_preprint":false},{"pmid":"41631390","id":"PMC_41631390","title":"Modulation of Ferroptosis by the Irx3-Etfa Pathway Protects Against Cardiac Hypertrophy.","date":"2026","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/41631390","citation_count":0,"is_preprint":false},{"pmid":"38700669","id":"PMC_38700669","title":"Pectin methylesterase activities in reproductive tissues of maize plants with different haplotypes of the Ga1 and Ga2 cross incompatibility systems.","date":"2024","source":"Plant reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/38700669","citation_count":0,"is_preprint":false},{"pmid":"41254678","id":"PMC_41254678","title":"First report of neonatal-onset glutaric aciduria type II in the Iranian population caused by a novel deleterious ETFA variant.","date":"2025","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/41254678","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.12.18.628907","title":"Climate drives long-term landscape and rapid short-term promoter evolution in the Western Canaries lizard,  <i>Gallotia galloti</i>","date":"2024-12-21","source":"bioRxiv","url":"https://doi.org/10.1101/2024.12.18.628907","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.12.02.626474","title":"Molecular evolution of a reproductive barrier in maize and related species","date":"2024-12-03","source":"bioRxiv","url":"https://doi.org/10.1101/2024.12.02.626474","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":21117,"output_tokens":1881,"usd":0.045783,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":8048,"output_tokens":1874,"usd":0.043545,"stage2_stop_reason":"end_turn"},"total_usd":0.089328,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"Looking at the corpus, I need to identify papers about the canonical human ETFA gene (electron transfer flavoprotein subunit alpha, associated with multiple acyl-CoA dehydrogenase deficiency / glutaric aciduria type II).\n\nMost papers in this corpus are about:\n- GA2 ganglioside / glycolipid metabolism (papers 1-4, 7-9, 12-14, 17, 21, 27, 32) — NOT ETFA\n- Plant GA2-oxidase / gibberellin catabolism (papers 5, 6, 11, 20, 23, 35, 38) — NOT ETFA\n- Microbial EtfA (Clostridium perfringens DPA synthase) (paper 10) — different protein\n- Viral/microbial GA2 genotypes (papers 16, 24, 33) — NOT ETFA\n- Fungal GA2 enzymes (papers 15, 25, 30) — NOT ETFA\n- ETFA gene variants in MADD patients (papers 19, 31, 36) — clinical reports, mostly no mechanism\n- Papers 18, 22, 26, 28, 34 — mention ETFA (the human electron transfer flavoprotein alpha)\n- Paper 37 (preprint) — mentions ETFA promoter evolution in lizards\n\nLet me evaluate papers 18, 22, 26, 28, 34 for mechanistic content about human/mammalian ETFA:\n\n- Paper 18: lncRNA regulatory study; identifies EZH2 activates ETFA by promoter methylation. Some mechanism.\n- Paper 22: miR-320b targets ETFA in HUVECs — target validation.\n- Paper 26: ETFA genotype association with antioxidant enzyme activity in sperm — no direct mechanism established.\n- Paper 28: PROTAC compound binds/stabilizes ETFA, enhancing ATP production — direct binding shown.\n- Paper 34: Irx3 transcription factor directly binds Etfa promoter and regulates ferroptosis in cardiac hypertrophy.\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2021,\n      \"finding\": \"EZH2, a transcriptional factor, activates ETFA expression by enhancing methylation of its promoter in colorectal cancer cells; lncRNA NBPF4 downregulates EZH2 and thereby suppresses ETFA expression.\",\n      \"method\": \"RNA pull-down assay, RNA immunoprecipitation, luciferase activity assay, Western blotting, qRT-PCR, silencing/overexpression in HCT116 and SW260 cells\",\n      \"journal\": \"Journal of cellular and molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — multiple orthogonal methods (RIP, luciferase, Western blot) in single lab; promoter methylation-mediated activation of ETFA by EZH2 supported but not independently replicated\",\n      \"pmids\": [\"34405537\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PMP-derived miR-320b directly targets ETFA mRNA in HUVECs; knockdown of ETFA (via miR-320b mimics) promoted HUVEC viability, proliferation, and migration under hypoxic conditions, and reduced oxidative stress and inflammatory markers (MDA, ROS, IL-6, TNF-α, IL-1β).\",\n      \"method\": \"miRNA target validation (implied luciferase/expression assays), Western blotting, MTT, EdU, wound healing assays in CoCl2-treated HUVECs\",\n      \"journal\": \"International heart journal\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, target relationship inferred from expression changes; abstract does not explicitly confirm direct 3'UTR luciferase validation of ETFA as miR-320b target\",\n      \"pmids\": [\"38556340\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"A pomalidomide-gefitinib PROTAC compound (P-G) directly binds and thermally stabilizes ETFA protein, enhancing ETFA-mediated ATP/energy production in EGFR-TKI-resistant NSCLC cells, which promotes apoptosis sensitization.\",\n      \"method\": \"Thermal shift assay (CETSA-type stabilization), cellular energy production assays, Western blotting, xenograft tumor model\",\n      \"journal\": \"Bioorganic chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct binding of small molecule to ETFA shown by thermal stabilization with functional consequence (ATP generation), single lab, single study\",\n      \"pmids\": [\"40815992\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"The transcription factor Irx3 directly binds the Etfa promoter and upregulates Etfa expression in cardiomyocytes; the Irx3-Etfa axis suppresses ferroptosis and attenuates pathological cardiac hypertrophy. Etfa knockdown abolished the cardioprotective effects of Irx3 overexpression, placing Etfa downstream of Irx3 in this pathway.\",\n      \"method\": \"AAV-mediated overexpression and shRNA knockdown in vivo (TAC mouse model) and in vitro (angiotensin II cardiomyocyte model), transcription factor binding assay (promoter binding), transcriptomic analysis, ferroptosis markers\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis (Etfa KD rescues Irx3 OE phenotype), direct promoter binding shown, orthogonal in vivo and in vitro models; single lab\",\n      \"pmids\": [\"41631390\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"A homozygous promoter variant in ETFA (c.-85G>A) causes decreased ETFA protein expression and reduced promoter activity, establishing that the ETFA promoter region is required for normal ETFA expression and that its disruption leads to MADD.\",\n      \"method\": \"Whole genome sequencing, promoter luciferase reporter assay, Western blotting of lymphoblast protein\",\n      \"journal\": \"American journal of medical genetics. Part A\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — luciferase assay directly tested promoter activity, Western blot confirmed reduced protein; single lab but two orthogonal methods\",\n      \"pmids\": [\"36579410\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ETFA (electron transfer flavoprotein subunit alpha) is a mitochondrial protein whose expression is driven by its promoter (regulated by transcription factor Irx3 and subject to EZH2-mediated epigenetic activation), and whose protein directly participates in mitochondrial energy (ATP) production; the Irx3-ETFA axis suppresses ferroptosis and cardiac hypertrophy, and loss-of-function ETFA variants (coding or promoter) cause multiple acyl-CoA dehydrogenase deficiency (MADD/glutaric aciduria type II) by impairing fatty acid and amino acid oxidation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ETFA encodes a mitochondrial protein that directly participates in cellular energy (ATP) production, a role demonstrated when a small-molecule PROTAC that binds and thermally stabilizes ETFA enhanced ETFA-mediated ATP generation in NSCLC cells [#2]. Beyond its bioenergetic function, ETFA serves as a downstream effector in stress and disease pathways: in cardiomyocytes the transcription factor Irx3 directly binds the Etfa promoter and upregulates its expression, and this Irx3–Etfa axis suppresses ferroptosis and attenuates pathological cardiac hypertrophy, with Etfa knockdown abolishing the cardioprotective effect of Irx3 [#3]. ETFA expression is regulated at the promoter level by multiple inputs, including EZH2-mediated promoter methylation in colorectal cancer cells [#0] and post-transcriptional targeting of ETFA mRNA by miR-320b in endothelial cells [#1]. A homozygous ETFA promoter variant (c.-85G>A) reduces promoter activity and ETFA protein, establishing that intact ETFA expression is required to prevent multiple acyl-CoA dehydrogenase deficiency (MADD) [#4]. Detailed enzymatic and structural characterization of ETFA's role in mitochondrial electron transfer has not been described in the available corpus.\",\n  \"teleology\": [\n    {\n      \"year\": 2021,\n      \"claim\": \"Established that ETFA expression is epigenetically controlled, identifying EZH2-mediated promoter methylation as an activating input subject to lncRNA regulation.\",\n      \"evidence\": \"RNA pull-down, RIP, luciferase, and silencing/overexpression in colorectal cancer cell lines\",\n      \"pmids\": [\"34405537\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not test the bioenergetic or metabolic consequences of altered ETFA levels\", \"Promoter methylation-mediated activation not independently replicated\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Demonstrated that the ETFA promoter region is functionally required for normal expression, linking promoter disruption directly to MADD pathology.\",\n      \"evidence\": \"Whole genome sequencing of a patient, promoter luciferase reporter assay, and Western blot of lymphoblasts\",\n      \"pmids\": [\"36579410\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single family/variant\", \"Does not resolve the downstream enzymatic defect at the protein level\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identified post-transcriptional control of ETFA by miR-320b in endothelial cells, connecting ETFA levels to oxidative stress and inflammatory output under hypoxia.\",\n      \"evidence\": \"miRNA mimic/knockdown, Western blot, and proliferation/migration assays in CoCl2-treated HUVECs\",\n      \"pmids\": [\"38556340\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Direct 3'UTR luciferase validation of ETFA as a miR-320b target not explicitly confirmed\", \"Target relationship inferred from expression changes\", \"Single lab\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Provided direct evidence that ETFA protein drives ATP/energy production, showing a small molecule that stabilizes ETFA enhances its bioenergetic function.\",\n      \"evidence\": \"Thermal shift (CETSA-type) binding assay, cellular energy production assays, and xenograft model in EGFR-TKI-resistant NSCLC\",\n      \"pmids\": [\"40815992\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of how ETFA stabilization increases ATP not resolved at the enzymatic level\", \"Single study\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Placed ETFA as a direct transcriptional target and effector of Irx3 that suppresses ferroptosis and cardiac hypertrophy, defining a protective signaling axis.\",\n      \"evidence\": \"AAV overexpression/knockdown in TAC mouse and angiotensin II cardiomyocyte models, promoter binding assay, and transcriptomics with ferroptosis markers\",\n      \"pmids\": [\"41631390\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular link between ETFA bioenergetic function and ferroptosis suppression unresolved\", \"Single lab\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The biochemical mechanism by which ETFA mediates mitochondrial electron transfer and how its energy function connects to ferroptosis and MADD pathology remains uncharacterized in this corpus.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model or enzymatic characterization in the timeline\", \"No identified direct protein partners in the electron transfer chain\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"complexes\": [],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":4,"faith_total":4,"faith_pct":100.0}}